These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Topical delivery of steroids in inflammatory bowel disease. Girlich C; Scholmerich J Curr Drug Deliv; 2012 Jul; 9(4):345-9. PubMed ID: 22762277 [TBL] [Abstract][Full Text] [Related]
25. Systematic review: the use of mesalazine in inflammatory bowel disease. Bergman R; Parkes M Aliment Pharmacol Ther; 2006 Apr; 23(7):841-55. PubMed ID: 16573787 [TBL] [Abstract][Full Text] [Related]
26. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001 [TBL] [Abstract][Full Text] [Related]
27. [Steroids in inflammatory bowel disease]. López San Román A; Garrido E Rev Esp Enferm Dig; 2015 Sep; 107(9):573. PubMed ID: 26334467 [No Abstract] [Full Text] [Related]
28. The new steroids: clinical experience in ulcerative colitis. Jewell DP Mt Sinai J Med; 1990 Oct; 57(5):293-6. PubMed ID: 1710774 [No Abstract] [Full Text] [Related]
29. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179 [TBL] [Abstract][Full Text] [Related]
30. [Classical medications in the treatment of inflammatory bowel diseases]. Duvnjak M; Bilić A; Barsić N; Tomasić V; Stojsavljević S Acta Med Croatica; 2013 Apr; 67(2):111-24. PubMed ID: 24471294 [TBL] [Abstract][Full Text] [Related]
31. How to do without steroids in inflammatory bowel disease. Present DH Inflamm Bowel Dis; 2000 Feb; 6(1):48-57; discussion 58. PubMed ID: 10701150 [TBL] [Abstract][Full Text] [Related]
32. [Advances in the topical steroid treatment of inflammatory bowel diseases]. Díaz Blasco J; Robledo Andrés P Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536 [No Abstract] [Full Text] [Related]
33. Reviewing the therapeutic role of budesonide in Crohn's disease. López-Sanromán A; Clofent J; Garcia-Planella E; Menchén L; Nos P; Rodríguez-Lago I; Domènech E Gastroenterol Hepatol; 2018; 41(7):458-471. PubMed ID: 30007787 [TBL] [Abstract][Full Text] [Related]
35. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases]. Ewe K Verh Dtsch Ges Inn Med; 1988; 94():178-84. PubMed ID: 2905098 [No Abstract] [Full Text] [Related]
36. Randomized controlled trials in active luminal Crohn's disease. Castiglione F; Rispo A Rev Recent Clin Trials; 2012 Nov; 7(4):290-6. PubMed ID: 23092232 [TBL] [Abstract][Full Text] [Related]
37. Medical treatment of inflammatory bowel disease: new therapies, new drugs. Sutherland LR CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889 [TBL] [Abstract][Full Text] [Related]
38. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease]. Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715 [No Abstract] [Full Text] [Related]